Work

Abstract A291: A highly selective dual insulin receptor (IR)/insulin-like growth factor 1 receptor (IGF-1R) inhibitor derived from an ERK inhibitor.

Year: 2013

Type: conference-abstract

Source: Molecular Cancer Therapeutics

DOI: 10.1158/1535-7163.targ-13-a291

Authors: Krisna C. Duong-Ly, Theonie Anastassiadis, Sean W. Deacon, Alec Lafontant, Haiching Ma, Karthik Devarajan, Roland L. Dunbrack, Jinhua Wu, Jeffrey R. Peterson

Institutions: Fox Chase Cancer Center, Reaction Biology Corporation (United States)

Language: English

Topic: Growth Hormone and Insulin-like Growth Factors

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2036058834

Cites:

Cited by: 1

Related to: 10